Tudor Investment Corp’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,232	Closed	-$26K	–	1542
2022 Q2	$26K	Hold	15,232	–	–	﹤0.01%	1512
2022 Q1	$31K	Sell	15,232 -670	-4%	-$1.36K	﹤0.01%	1467
2021 Q4	$60K	Sell	15,902 -102	-0.6%	-$385	﹤0.01%	1535
2021 Q3	$83K	Buy	+16,004	New	+$83K	﹤0.01%	1472